Patents by Inventor Susan Kalled

Susan Kalled has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
    Patent number: 9545086
    Abstract: The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: January 17, 2017
    Assignee: Biogen MA Inc.
    Inventors: Fabienne MacKay, Susan Kalled
  • Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA
    Patent number: 9387237
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: July 12, 2016
    Assignee: BIOGEN MA INC.
    Inventors: Susan Kalled, Sambasiva Rao
  • Methods of evaluating BAFF
    Patent number: 9097726
    Abstract: The present disclosure provides compositions and methods relating to the evaluation of BAFF in a biological sample from a subject.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: August 4, 2015
    Assignee: Biogen MA Inc.
    Inventors: Yen-Ming Hsu, Susan Kalled
  • METHODS OF TREATING A PATIENT HAVING AN AUTOIMMUNE DISORDER BY ADMINISTERING A BAFF ANTAGONIST
    Publication number: 20150098953
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorder are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round or administration.
    Type: Application
    Filed: August 1, 2014
    Publication date: April 9, 2015
    Inventors: Susan Kalled, Sambasiva Rao
  • Methods of Evaluating BAFF
    Publication number: 20140273019
    Abstract: The present disclosure provides compositions and methods relating to the evaluation of BAFF in a biological sample from a subject.
    Type: Application
    Filed: February 13, 2014
    Publication date: September 18, 2014
    Applicant: Biogen Idec MA Inc.
    Inventors: Yen-Ming Hsu, Susan Kalled
  • Method of treating a patient having an autoimmune disorder by administering BAFFR polypeptide
    Patent number: 8828948
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: September 9, 2014
    Assignee: Biogen Idec MA Inc.
    Inventors: Susan Kalled, Sambasiva Rao
  • Methods of evaluating BAFF
    Patent number: 8685657
    Abstract: The present disclosure provides compositions and methods relating to the evaluation of BAFF in a biological sample from a subject.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: April 1, 2014
    Assignee: Biogen Idec MA Inc.
    Inventors: Yen-Ming Hsu, Susan Kalled
  • METHOD OF TREATING A PATIENT HAVING AN AUTOIMMUNE DISORDER BY ADMINISTERING BAFFR POLYPEPTIDE
    Publication number: 20130230538
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Application
    Filed: November 22, 2011
    Publication date: September 5, 2013
    Inventors: Susan Kalled, Sambasiva Rao
  • Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA
    Patent number: 8084030
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: December 27, 2011
    Assignee: Biogen Idec MA Inc,
    Inventors: Susan Kalled, Sambasiva Rao
  • Therapeutic regimens for BAFF antagonists
    Publication number: 20110110950
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Application
    Filed: October 20, 2010
    Publication date: May 12, 2011
    Inventors: Susan KALLED, Sambasiva Rao
  • Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR
    Patent number: 7850967
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: December 14, 2010
    Assignee: Biogen IDEC MA Inc.
    Inventors: Susan Kalled, Sambasiva Rao
  • BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders
    Publication number: 20090110676
    Abstract: The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
    Type: Application
    Filed: April 2, 2008
    Publication date: April 30, 2009
    Inventors: FABIENNE MACKAY, SUSAN KALLED
  • Use of Baff to Treat Th2-Mediated Conditions
    Publication number: 20080254030
    Abstract: Compositions and methods for treating Th2-mediated disease are provided.
    Type: Application
    Filed: January 27, 2006
    Publication date: October 16, 2008
    Inventors: Charles Mackay, Fabienne Mackay, Susan Kalled
  • Therapeutic Regimens for Baff Antagonists
    Publication number: 20070269443
    Abstract: Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
    Type: Application
    Filed: October 20, 2004
    Publication date: November 22, 2007
    Inventors: Susan Kalled, Sambasiva Rao
  • Treament of lupus nephritis with anti-CD40L compounds
    Publication number: 20070190053
    Abstract: This invention relates to methods for treatment of nephritis associated with immune complex disease using anti-CD40L compounds. According to one embodiment of this invention, anti-CD40L compounds are administered to a patient with immune complex disease who has received a kidney allograft, to inhibit the development of immune complex glomerulonephritis within the grafted kidney.
    Type: Application
    Filed: September 25, 2006
    Publication date: August 16, 2007
    Inventors: Susan Kalled, David Thomas
  • BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
    Publication number: 20050244411
    Abstract: The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
    Type: Application
    Filed: February 24, 2005
    Publication date: November 3, 2005
    Inventors: Fabienne MacKay, Susan Kalled
  • Method of therapeutic administration of anti-CD40L compounds
    Publication number: 20050158314
    Abstract: This invention relates to regimens for therapeutically administering anti-CD40L compounds to patients. Immune-related disorders can be effectively treated by administering anti-CD40L compounds at intervals of three weeks or more.
    Type: Application
    Filed: December 23, 2004
    Publication date: July 21, 2005
    Inventors: Susan Kalled, David Thomas
  • BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
    Publication number: 20030095967
    Abstract: The invention provides methods for treating or preventing disorders associated with expression of BAFF comprising BAFF and fragments thereof, antibodies, agonists and antagonists.
    Type: Application
    Filed: November 7, 2001
    Publication date: May 22, 2003
    Inventors: Fabienne MacKay, Susan Kalled